Status:
UNKNOWN
Artificial Intelligence Guided Personalised Medicine in Patients With Hypertension and Diabetes
Lead Sponsor:
Alexandra Hospital
Conditions:
Diabetes Mellitus
Hypertension
Eligibility:
All Genders
21+ years
Brief Summary
Hypertension and diabetes are chronic diseases that require long-term management and disease control is often sub-optimal, leading to complications which place additional burden on patients and the he...
Detailed Description
The aim of this study is demonstrate that artificial intelligence guided treatment in chronic disease of hypertension and type 2 diabetes mellitus will yield actionable medication dosing optimization....
Eligibility Criteria
Inclusion
- Adult patients (≥ 21years) with T2DM or hypertension
- Expected to be followed up in Alexandra Hospital for the next 4-months
- Signed informed consent form
Exclusion
- Patients with cognitive impairment
- Patients with active cancer undergoing chemotherapy
- Patients on hemodialysis or peritoneal dialysis (which can cause rapid fluctuation of BP and blood sugar, respectively)
- Pregnant patients
- Patients whose medications for T2DM and hypertension are changed simultaneously during the first clinic visit
- Serious concomitant disorders that would compromise the safety of the patient or compromise the patient's ability to complete the study, at the discretion of the investigator.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04769141
Start Date
August 1 2021
End Date
January 1 2023
Last Update
July 22 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.